You’ve built something valuable. Maybe it’s a manufacturing process in Toronto, a software workflow used by clients in New York, or a product design you’re preparing to launch on both sides of the border. The question usually arrives earlier than founders expect. Should you patent it, or keep it secret?
At Mayo Law, our attorneys regularly see this issue arise when a startup moves from early traction to expansion. A choice that looks simple in one country gets much more complicated when your staff, vendors, investors, and customers sit in both Ontario and New York. The wrong move may expose the idea, weaken enforcement, or create avoidable diligence problems later.
Trade secret vs patent isn’t just an IP question. It’s a business structure, compliance, litigation, and cross-border risk question too. In some cases, tools like software escrow planning also belong in the discussion because protection often depends on how the asset is controlled.
Protecting Your Innovation Across the US-Canada Border
A founder in Ontario develops a process that cuts production waste. The process sits partly in machine settings, partly in staff know-how, and partly in internal documentation. Then a distributor in New York wants exclusivity, an investor wants diligence materials, and a senior employee leaves for a competitor.
That’s the moment the trade secret vs patent decision stops being theoretical.
A patent can look attractive because it creates a defined right you can point to in a deal room or courtroom. A trade secret can look smarter because it avoids disclosure and may last indefinitely if you keep it confidential. The problem is that many companies choose based on instinct instead of how the asset will be used, shared, and challenged across borders.
What founders often miss
The legal answer depends on practical facts:
- Who can access it: If your process is already circulating among vendors, consultants, and cross-border employees, secrecy may be harder to maintain.
- How easy it is to copy: If a competitor can inspect the product and figure out the innovation, secrecy often breaks down fast.
- Why the business needs protection: Investor diligence, licensing, and enforcement each favor different tools.
Practical rule: Protect the asset based on how it lives inside your business, not on which label sounds stronger.
Understanding Patents and Trade Secrets in US and Canadian Law
A patent is a government-granted right. In practical terms, it lets the owner stop others from making, using, or selling the claimed invention, even if the other party developed it independently. In the United States, patent rights are shaped by federal law and processed through the USPTO. In Canada, comparable filings run through CIPO.
A trade secret is different. It isn’t registered. Protection comes from the fact that the information is secret, has commercial value because it’s secret, and is subject to reasonable measures to keep it secret.
What a patent really gives you
Patents are strongest when the innovation can be observed, tested, or reverse-engineered. They also fit businesses that need a clearly defined asset for licensing, financing, or acquisition. The core bargain is straightforward. You disclose the invention publicly, and in exchange you receive a time-limited exclusive right.
If infringement happens, you’re usually arguing over whether another party’s product or process falls within the patent claims. That’s still complex, but it’s often more structured than proving a secret existed and was wrongfully taken. Businesses dealing with copying concerns often need counsel that understands both enforcement and dispute posture, especially where patent infringement issues may overlap with commercial strategy.
What a trade secret really requires
Trade secrets protect know-how, formulas, methods, pricing models, source code elements, customer intelligence, and internal processes. But secrecy isn’t a vibe. It’s an operating discipline.
In both U.S. and Canadian settings, trade secret protection usually depends on measures such as:
- Contract controls: NDAs, confidentiality clauses, invention assignment terms, and offboarding paperwork.
- Access limits: Need-to-know permissions, segmented files, and restricted vendor access.
- Security practices: Internal policies, technical restrictions, and document handling rules.
A trade secret exists because a business treats the information like a secret every day, not because the business says it’s confidential after a dispute starts.
That distinction matters in New York and Ontario. If your own people treat sensitive information casually, courts often notice.
Core Differences A Head-to-Head Comparison
Early in the decision process, founders need a side-by-side view.
| Issue | Patent | Trade secret |
|---|---|---|
| Duration | 20 years from filing | Potentially indefinite if secrecy holds |
| Disclosure | Full public disclosure required | No public filing required |
| Protection against independent invention | Yes | No |
| Protection against reverse engineering | Yes | No |
| Startup cost | Typically $10,000-$30,000+ USD initially | Minimal upfront fees, but security costs continue |
| How protection starts | After filing and grant process | Immediately if the information is secret and controlled |
Duration and disclosure
The cleanest legal divide is duration. Patents provide 20 years of protection from the filing date and require public disclosure, while trade secrets may last indefinitely if confidentiality is maintained, as outlined in this patent and trade secret comparison.
That tradeoff is more than academic. If your advantage depends on hidden process details, a patent may hand competitors a roadmap after the term ends. If your advantage is easy to discover once the product launches, secrecy may fail almost immediately.
Cost and timing
Patents demand money early. Filing, prosecution, and maintenance create a real budget item. Trade secrets avoid registration cost, but they aren’t free. You pay through policies, system controls, training, contract discipline, and sometimes forensic cleanup after a leak.
A founder who says trade secrets are cheap often means only that no filing fee was paid.
Scope and enforceability
A patent reaches independent development. That’s a major commercial benefit. If a competitor arrives at the same result on its own, the patent may still block them.
Trade secrets don’t do that. They protect against misappropriation, not lawful discovery. If a rival reverse-engineers your product or independently develops the same process, secrecy may provide no remedy.
What works and what doesn’t
What works:
- Patenting visible, inspectable innovation
- Using trade secrets for hidden processes and internal know-how
- Matching the protection tool to how competitors would copy it
What usually doesn’t:
- Calling something a trade secret after broad internal sharing
- Patenting an invention before thinking through disclosure consequences
- Assuming one form of protection fits the entire business asset
Don’t ask which tool is stronger in the abstract. Ask which one still helps you after launch, hiring, fundraising, and a dispute.
Cross-Border Enforcement Realities for NY and ON Businesses
The hard part isn’t choosing a label. The hard part is what happens when someone in one country uses your asset and your company has to respond in another.
Why patents are often more predictable
For cross-border businesses, patents usually offer a more defined enforcement path. The right is registered, the claimed invention is identified, and counterpart filings can be coordinated across jurisdictions. That clarity matters when a board, investor, or buyer asks what exactly the company owns.
A cross-border summary from Heimlich Law on patents and trade secrets states that U.S. patents offer strong cross-border protection via the PCT, while trade secrets rely on more fragile common law alignment. The same source notes that SMEs lose 40% more trade secret cases internationally due to proof burdens.
That proof burden is the core issue. In a patent case, the argument often centers on claim scope and use. In a trade secret case, you may have to prove the secret existed, that it was genuinely secret, that reasonable measures protected it, that the defendant acquired or used it improperly, and that the evidence crosses the border cleanly.
Why trade secret cases get messy fast
A New York employee may access files stored in Ontario. An Ontario contractor may forward process documents to a U.S. affiliate. A former executive may claim the know-how was general skill, not protected information.
Those facts create friction in several places:
- Evidence collection: Who had access, where data sat, and which contracts govern the relationship.
- Choice of law: U.S. federal trade secret claims don’t map perfectly onto Canadian common law and provincial approaches.
- Remedy strategy: Emergency relief may be available, but only if the record is strong and the secrecy measures were real.
When the dispute belongs in arbitration rather than court, enforceability planning also matters. Businesses with cross-border contracts often benefit from building dispute terms early, including with counsel familiar with Ontario and international arbitration enforcement.
Cross-border trade secret litigation often turns into a document and process audit of your own business before it reaches the merits of the theft claim.
M&A and diligence pressure
This issue shows up long before litigation. In diligence, buyers want clean ownership, documented controls, and a believable story about how the company protected critical know-how. Patents are easier to inventory. Trade secrets require proof of operational discipline.
If the diligence file is thin, value discussions may get harder.
IP Risks in White-Collar and Regulatory Investigations
Many companies treat trade secrets as a cleaner, quieter alternative to patents. That assumption can break down during a government investigation.
A patent is already public. A trade secret is only valuable if the company can keep control over it. During fraud, insider trading, tax, securities, or internal misconduct probes, executives may face subpoenas, interviews, forensic imaging, preservation demands, or internal reporting obligations that pull confidential information into the open.
The exposure problem
Once sensitive material moves through investigators, outside counsel, regulators, auditors, or internal special committees, the company needs tight protocols. If the process is sloppy, the business may later struggle to argue that it took reasonable steps to preserve secrecy.
That’s one reason trade secret planning belongs in compliance discussions, not just IP meetings.
Reasonable measures are not optional
A discussion of trade secret and patent overlap from NYU JIPEL notes that trade secrets are uniquely vulnerable in white-collar investigations where disclosure may be compelled. The same source states that post-2025 DTSA amendments mandate strict reasonable measures and that non-compliance has led to dismissal rates as high as 28% in recent federal cases involving misappropriation allegations surfacing during fraud or insider trading probes.
That should get management’s attention. If your company relies on secrecy, the record has to show actual controls, not just confidentiality language in a handbook.
Practical pressure points include:
- Internal investigations: Who gets access to technical files, and under what restrictions.
- Regulator responses: How disclosures are staged, logged, and limited.
- Executive conduct: Whether founders used personal devices, personal email, or informal channels for sensitive material.
A trade secret program that fails during an investigation was weak before the investigation started.
Companies facing this kind of overlap often need coordinated IP, employment, and defense planning, especially where the same facts may trigger commercial claims and government scrutiny. That’s why businesses under pressure sometimes need support from attorneys handling white-collar crimes defense.
Strategic Scenarios When to Choose a Patent or Trade Secret
The best choice usually becomes clearer when you stop speaking in categories and start looking at the asset itself.
Choose a patent when the product reveals the idea
Suppose you’ve built a hardware device that will be sold broadly in the U.S. and Canada. Once it’s in the market, competitors can buy it, test it, disassemble it, and study how it works. In that setting, secrecy rarely lasts. A patent is often the stronger tool because it protects against independent development and reverse engineering.
The same logic often applies to medical devices, visible mechanical systems, and product features that must be shown to customers, regulators, or manufacturing partners.
Choose a trade secret when the edge sits behind the curtain
Now take a process innovation. Maybe it’s a recipe, a calibration method, a workflow for using software, or a manufacturing sequence that outsiders can’t easily detect from the finished product. A trade secret may make more sense if the company can keep the information compartmentalized and secure.
That pattern isn’t unusual. The National Center for Science and Engineering Statistics reports that among U.S. businesses conducting or funding R&D, 76.2% viewed trade secrets as an important form of IP protection, compared with 49.4% for utility patents, according to this NCSES report on business IP protection. Industry strategy varies. Beverage and tobacco manufacturers place especially high value on trade secrets, while pharmaceuticals place far greater value on utility patents.
What founders should ask by industry
A few examples help:
- Consumer product startup: If the product can be inspected, a patent often deserves serious consideration.
- Food and beverage business: If the value is in a formula or process that can stay hidden, trade secret protection may be attractive.
- Life sciences company: If investment and regulatory strategy depend on defined exclusivity, patents often matter more.
- Software company: The answer may split. Some code-related methods are better held in confidence, while visible technical features may raise patent questions.
Industry norms matter because investors, acquirers, and competitors often evaluate your IP through the lens of what the market expects.
Combining Protections The Hybrid IP Strategy
The strongest answer is often neither “patent everything” nor “keep everything secret.” It’s a selective combination.
A business may patent the part of the innovation that competitors can study from the product itself, while keeping internal know-how, manufacturing settings, implementation methods, and QA tolerances confidential. That approach often fits cross-border businesses because it separates what must be disclosed from what still creates internal advantage.
A practical benchmark
A useful benchmark appears in this hybrid patent and trade secret discussion. If a competitor can figure out the innovation in under two years, a patent is often the better tool. If the process is hard to crack, a trade secret may provide indefinite protection. The same source points to Coca-Cola’s formula as a well-known example of secrecy lasting for over 100 years.
That framework helps founders avoid false binaries.
How a hybrid structure looks in practice
A hybrid plan often includes:
- Patent the outward-facing invention: Product architecture, visible features, or core mechanisms that can be discovered through testing.
- Keep process know-how secret: Temperatures, ratios, sequencing, training materials, internal scripts, and implementation methods.
- Paper the ownership chain: Consultant agreements, employee invention assignments, and deal terms need to match the protection model.
This becomes especially important in transactions. If a company licenses or sells part of the business, the transfer documents need to distinguish registered IP from confidential know-how. Sloppy drafting in an assignment of contract and rights context can create avoidable ownership fights later.
The best hybrid strategies map each asset to the way competitors would actually obtain it.
Your Cross-Border IP Decision Checklist
A short checklist often gets founders to the right answer faster than a long debate.
Key considerations
- Can a competitor reverse-engineer it? If yes, a patent may deserve priority.
- Do you need protection against independent invention? Trade secrets won’t give you that.
- Can your team keep it secret? Shared folders, vendor access, and weak offboarding often undermine trade secret claims.
- How important is diligence readiness? Patents are easier to inventory. Trade secrets require proof of controls.
- Will regulators, auditors, or investigators need access? Sensitive information under scrutiny may create extra trade secret risk.
- Are you operating in both New York and Ontario? Cross-border proof problems tend to hit trade secret claims harder.
- Is a split strategy better? One asset may justify both patent filing for visible features and secrecy for implementation know-how.
Implementation points
Once you’ve chosen a direction, execution matters:
- Tighten contracts early. NDAs, invention assignments, contractor terms, and exit documents should line up.
- Limit access. Need-to-know access supports secrecy better than broad internal sharing.
- Document ownership. If a dispute or diligence process starts, clean records save time and credibility.
Build Your Business on Solid Legal Ground
A startup can spend years building a process that gives it a real edge, then lose negotiating power in a week because the IP plan did not match how the business operates across New York and Ontario.
That is the practical point behind the trade secret versus patent decision. It affects financing, hiring, joint development work, internal controls, dispute strategy, and what happens if a regulator, prosecutor, or forensic vendor demands access to sensitive records. For cross-border companies, those pressures show up early. A protection strategy that looks sound on paper can weaken quickly if ownership records are split, confidentiality practices are inconsistent, or enforcement would have to run on both sides of the border.
Founders should treat this as a business risk allocation decision, not just an IP filing question. The right choice depends on the asset, the market, and your ability to prove and defend your position under scrutiny.
Mayo Law advises startups and SMEs operating between Ontario and New York. If you are weighing patent protection, trade secret controls, or a hybrid approach, schedule a consultation with Mayo Law.
Legal Disclaimer
LEGAL DISCLAIMER: This article provides general information only. It is not legal advice and should not be treated as advice for any specific patent, trade secret, regulatory, or litigation issue. Reading this article, contacting Mayo Law, or requesting information does not create an attorney-client relationship.
Cross-border IP disputes turn on facts, documents, timing, and jurisdiction. That is particularly true for businesses operating between New York and Ontario, where the practical outcome can change based on contract language, confidentiality controls, employee conduct, record retention, and how sensitive material is handled during investigations or regulatory demands.
Legal rules, court procedures, and enforcement options differ by jurisdiction and change over time. Any decision about filing a patent application, maintaining a trade secret, responding to a subpoena, or producing records in an internal or government investigation should be reviewed with counsel qualified in the relevant jurisdiction.
Mayo Law disclaims liability for actions taken or not taken based on this article. If your business is expanding between New York and Ontario, Mayo Law may help you assess whether a patent, a trade secret, or a hybrid approach fits your commercial goals, compliance posture, and cross-border risk profile. Schedule a consultation to discuss your business.
